In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers

Pharmaceutical Research

Volumn 24, Issue 1, 2007, Pages 125-135

  Traini, Daniela ^a,b   Young, Paul M ^a   Rogueda, Philippe ^c   Price, Robert ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Bath   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Adhesive cohesive forces; AFM; In vitro testing; pMDI; Suspensions

Indexed keywords

BUDESONIDE; FORMOTEROL FUMARATE; PERFLUOROPENTANE; PROPELLANT; SALBUTAMOL SULFATE;

ADHESION; AEROSOL; ARTICLE; ATOMIC FORCE MICROSCOPY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; IN VITRO STUDY; METERED DOSE INHALER; MOLECULAR INTERACTION; PARTICLE SIZE; PRIORITY JOURNAL; SUSPENSION;

ADHESIVENESS; AEROSOL PROPELLANTS; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; BUDESONIDE; CENTRIFUGATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOLAMINES; METERED DOSE INHALERS; MICROSCOPY, ATOMIC FORCE; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SUSPENSIONS;

EID: 33845448975     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9130-2     Document Type: Article

References (25)

1. P. J. Barnes, M. M. Grunstein, A. R. Leff, and A. J. Woolcock. Asthma, Lippincott-Raven, Philadelphia, 1997.
2. R. N. Dalby and J. Suman. Inhalation therapy: technological milestones in asthma treatment. Adv. Drug Deliv. Rev. 55:779-791 (2003).
3. H. D. C. Smyth. Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 2:53-74 (2005).
4. A. Brindley. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurised metered dose inhaler suspension stability. J. Allergy Clin. Immunol. 104:S221-S226 (1999).
5. D. Traini, P. Rogueda, P. M. Young, and R. Price. Surface energy and interparticle forces correlations in model pMDI formulations. Pharm. Res. 22:816-825 (2005).
6. R. J. Good and L. A. Girifalco. A theory for estimation of surface and interfacial energies. III. Estimation of surface energies of solids from contact angle data. J. Phys. Chem. 64:561-565 (1960).
7. F. M. Fowkes. Determination of interfacial tension, contact angles and dispersion forces in surface by assuming additivity of intermolecular interactions in surfaces. J. Phys. Chem. 66:382 (1962).
8. C. J. van Oss. Interfacial Forces in Aqueous Media. Marcel Dekker, New York, U.S.A., 1994.
9. P. Begat, D. A. V. Morton, J. N. Staniforth, and R. Price. The cohesive-adhesive balances in dry powder inhaler formulations I: direct quantification by atomic force microscopy. Pharm. Res 21:1591-1597 (2004).
10. Apparatus D, British Pharmacopoeia. The Stationery Office on behalf of the Medicines and Healthcare Products Regulatory Agency (MHRA). London, UK, 2005.
11. N. J. C. Snell and D. Ganderton. Assessing lung deposition of inhaled medications: consensus statement from a workshop of the British Association for Lung Research. Respir. Med. 93:123-133 (1999).
12. C. G. Thiel. Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers? J. Aerosol Med. 11:S43-S52 (1998).
13. P. A. Webb and C. Orr. Analytical Methods in Fine Particle Technology, Micrometrics Instrument Corp., Norcross, Georgia, U.S.A., 1997.
14. G. Rhodes. Crystallography - Made Crystal Clear, Academic, New York, U.S.A., 1993.
15. J. Albertsson, A. Oskarsson, and C. Svensson. X-ray study of budesonide: molecular structure and solid solution of the (22S) and (22R) epimers of 11B,21-dihydroxy-16alfa,17 alfa-propylmethylenedioxy-1,4-pregnadiene-3,20-dione. Acta Crystallogr. B34:3027-3036 (1978).
16. Ertan, B. Stensland, and I. Ymen. Crystal and molecular structure of formoterol fumarate dihydrate, Astra Production Chemicals AB, Confidential Report N. 117/97, 1997.
17. P. J. M. Leger, M. Goursolle, and M. Gadret. Structure cristalline du sulphate de salbutamol [ter-butylamino-2-(hydroxy-4hydroxymethyl-3 phenyl)-1 ethanol.1/2 H2SO4]. Acta Crystallogr. B34:1203-1208 (1978).
18. W. A. Ducker, T. J. Senden, and R. M. Pashley. Direct measurement of colloidal forces using an atomic force microscope. Nature 353:239-241 (1991).
19. P. M. Young. Characterisation of particle-particle interactions using the atomic force microscope, Pharmacy and Pharmacology, University of Bath, Bath, UK, 2002.
20. Y. Michael, M. J. Snowden, B. Z. Chowdhry, I. C. Ashurst, C. J. Davies-Cutting, and T. Ripley. Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system. Int. J. Pharm. 221:165-174 (2001).
21. E. M. Phillips, P. R. Byron, and R. N. Dalby. Axial-ratio measurements for early detection of crystal-growth in suspension-type metered dose inhalers. Pharm. Res.10:454-456 (1993).
22. P. G. A. Rogueda. HPFP, a model propellant for pMDIs. Drug Dev. Ind. Pharm. 29:39-49 (2003).
23. J. N. Pritchard. The influence of lung deposition on clinical response. J. Aerosol Med. 14:S19-S26 (2001).
24. W. Neumann, D. R. Renzow, H. Reumuth, and J. E. Richter. Vol. 55, Fortschr. Kolloide Polymere 49-54 (1971)
25. G. Buckton. Interfacial Phenomena in Drug Delivery and Targeting, Harwood Academic Publishers, Chur, Switzerland, 1995.